Skip to main content

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Estudi i identificació de nous gens de senescència i factors pivot o comodí en senyalització cel·lular, l'angiogènesi i la invasivitat en carcinomes de còlon i mama. Una correlació clinicopatològica

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Matilde Lleonart Pajarin, Josep Tabernero Caturla, Manuel Armengol Carrasco, Eloy Espín Basany, Javier Hernandez Losa
Funding agency: Fundació La Marató de TV3
Funding: 245453
Reference: TV3/052710
Duration: 01/01/2006 - 31/12/2008

Estudio e identificación de nuevos genes de senescencia y factores pivotales o comodines en señalización celular, angiogénesis e invasividad en carcinomas humanos: correlación clínico-patológica

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Matilde Lleonart Pajarin, Angel García Jiménez, Josep Castellví Vives, Javier Hernandez Losa
Funding agency: Instituto de Salud Carlos III
Funding: 102340
Reference: PI050818
Duration: 01/01/2006 - 31/12/2009

Imiten les cèl·lules canceroses l'estratègia de les cèl·lules mare embrionàries per ser immortals?

IP: Matilde Lleonart Pajarin
Collaborators: Santiago Ramon y Cajal Agüeras
Funding agency: Fundació La Marató de TV3
Funding: 221100
Reference: TV3/052130
Duration: 01/01/2006 - 31/12/2009

Implicacions del receptor del virus de l'hepatitis A humà (hHAVcr-1) en el desenvolupament i la progressió del carcinoma renal. Valor com a marcador diagnòstic i pronòstic en els carcinomes de bufeta i renals

IP: Anna Meseguer Navarro
Collaborators: Santiago Ramon y Cajal Agüeras, Joan Morote Robles, Enric Trilla Herrera
Funding agency: Fundació La Marató de TV3
Funding: 204625
Reference: TV3/052410
Duration: 01/01/2006 - 30/04/2010

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Carlos Hobeich Naya

Carlos Hobeich Naya

Research technician
Transfusional Medicine
Read more
Aroa Gomez Brey

Aroa Gomez Brey

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Albert Moreno Mingorance

Albert Moreno Mingorance

Postdoctoral researcher
Microbiology
Read more
Raquel Ibarz Lopez

Raquel Ibarz Lopez

Administration and Management
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.